Follow NCPIE on Facebook

View our YouTube channel

Please consult a licensed health care professional with questions or concerns about your medication and/or condition.

Last Updated
April 19, 2017
NEWSROOM > Latest News > All
Current | 2016 News | 2015 News | Prior to 2015

- - - - -
January 27, 2017
Race, Gender Plays Role in College Students’ Misuse of Prescription Stimulants
A new study found significant racial and gender differences in use of stimulants on college campuses. White students 
were more likely to have prescriptions for the drugs. Asians and Latinos in the study were more likely to engage in 
smoking prescription stimulants, which can alter the rate of release, absorption, bioavailability and reinforcing effects 
of the drug, which could increase vulnerability for dependence. The researchers also found that Asians and Latinos 
were more likely to pay more for the pills than white students. Whites were more likely to take the drugs to party 
longer or to improve concentration. The only gender difference was the motivation to lose weight.
In Summary: Illicit use of prescription stimulants is increasing on college campuses and there appear to be important 
differences in how these drugs are used by different racial groups. It’s possible that targeted interventions among 
Asian and Latino students could focus on the additional risks associated with smoking the drugs. Those working with 
young women may wish to address the use of these drugs as a weight-loss tool.  (Source:  Cruz S, Sumstine S, 
Menendez J, Bavarian N (2017) Health-compromising practices of undergraduate college students: Examining 
racial/ethnic and gender differences in characteristics of prescription stimulant misuse, Addictive Behaviors, 68, 59-65.)
Related from NCPIE: College Resource Kit

January 27, 2017
Safe Use of Acetaminophen – FDA Resources for Action
The FDA is providing educational messaging to extend the reach of its Safe Use of Acetaminophen 
campaign to educate the public on the proper use of over-the-counter (OTC) medicines and to warn that taking too 
much acetaminophen can be dangerous. The campaign website offers resources for consumers, health professionals, 
organizations, and campaign supporters on improving consumer safety.

Acetaminophen is an active ingredient found in hundreds of over-the-counter (OTC) and prescription medicines that 
are used to relieve pain and fever. It is also combined with other active ingredients in medicines that treat allergy, 
cough, colds, flu, and sleeplessness. In prescription medicines, acetaminophen is found with other active ingredients to 
treat moderate to severe pain. Using two or more medicines that contain acetaminophen or using more acetaminophen 
than directed can cause serious liver damage.

Related from NCPIE:   
Acetaminophen Safe Use Modules

January 23, 2017
FDA warns -- Pet Illness and Death from Human Cancer Medication
FDA is warning about the possibility of illness or death in pets exposed to the topical cancer drug fluorouracil cream 
USP 5% (5-FU). The agency cautioned pharmacists, health care providers, veterinarians, and pet owners that it has 
received reports of five dogs that became sick and died after accidentally ingesting the cream. People who use the 
drug should use care when storing and applying the drug if they are in a household with pets, FDA said, noting that 
even minute amounts can be dangerous for pets. FDA has not received any reports involving cats; however, they are 
also expected to be sensitive to the drug. The cream may also be marketed under the brand names Carac, Effudex, 
and Fluoroplex.

January 12, 2017
NEW CDC Tool – Antibiotic Resistance Investment Map
An interactive web app with state-by-state fact sheets describing CDC’s key investments to combat antibiotic 
resistance and protect patients across the nation.  Using fiscal year 2016 funding data, the AR Investment Map and 
fact sheets can be used to better understand how CDC supports AR activities locally. With these investments, the 
Centers for Disease Control & Prevention (CDC), in partnership with health departments, academia, and healthcare, is 
transforming how the nation combats and slows antibiotic resistance at all levels.

January 11, 2017
First NY Recovery High Schools Created to Help Young People in Recovery Finish School
New York’s Governor Cuomo announced in his 2017 State of the State report that he will propose legislation to create 
New York’s first recovery high schools in regions of the State hit especially by the disease of addiction --one upstate 
and one downstate, in partnership with local social service agencies.  Enrollment will be open to all high school 
students with a diagnosis of a substance abuse disorder and a commitment to recovery.  Recovery schools are “schools 
within school” where students in recovery can learn in a substance-free and supportive environment and have proven 
to be an effective model to help youth in recovery stay healthy and graduate.